Aura Biosciences, Inc. (AURA)
6.47
+0.12
(+1.89%)
USD |
NASDAQ |
Dec 10, 16:00
6.475
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Cash from Investing (Quarterly): -44.02M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| 4D Molecular Therapeutics, Inc. | 17.78M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
| Oragenics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.14M |
| Cash from Financing (Quarterly) | 4.363M |
| Free Cash Flow | -88.80M |
| Free Cash Flow Per Share (Quarterly) | -0.3062 |
| Free Cash Flow to Equity (Quarterly) | -19.83M |
| Free Cash Flow to Firm (Quarterly) | -20.19M |
| Free Cash Flow Yield | -24.51% |